Kelly Patrick F. 4
4 · Forma Therapeutics Holdings, Inc. · Filed Feb 25, 2022
Insider Transaction Report
Form 4
Kelly Patrick F.
SVP, Chief Medical Officer
Transactions
- Sale
Common Stock
2022-02-23$9.78/sh−5,245$51,283→ 64,884 total
Footnotes (3)
- [F1]Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.61 to $10.005. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F3]The Form 4 filed by the reporting person on March 2, 2021 inadvertently understated the number of shares of Common Stock directly held by the reporting person by 42,959 shares.